nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—Hypochloraemia—Furosemide—dilated cardiomyopathy	0.0552	0.0646	CcSEcCtD
Guanabenz—Hypovolaemia—Furosemide—dilated cardiomyopathy	0.0275	0.0322	CcSEcCtD
Guanabenz—Instillation site pain—Furosemide—dilated cardiomyopathy	0.0262	0.0306	CcSEcCtD
Guanabenz—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0255	0.0298	CcSEcCtD
Guanabenz—Shoulder pain—Lisinopril—dilated cardiomyopathy	0.0238	0.0278	CcSEcCtD
Guanabenz—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0161	0.0188	CcSEcCtD
Guanabenz—Drug eruption—Furosemide—dilated cardiomyopathy	0.0139	0.0162	CcSEcCtD
Guanabenz—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.0134	0.0157	CcSEcCtD
Guanabenz—Appetite absent—Lisinopril—dilated cardiomyopathy	0.0129	0.0151	CcSEcCtD
Guanabenz—Renal pain—Lisinopril—dilated cardiomyopathy	0.0122	0.0143	CcSEcCtD
Guanabenz—Blister—Furosemide—dilated cardiomyopathy	0.0118	0.0139	CcSEcCtD
Guanabenz—Fluid overload—Lisinopril—dilated cardiomyopathy	0.0103	0.012	CcSEcCtD
Guanabenz—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0103	0.012	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0103	0.012	CcSEcCtD
Guanabenz—Psoriasis—Lisinopril—dilated cardiomyopathy	0.0102	0.0119	CcSEcCtD
Guanabenz—Gastritis—Spironolactone—dilated cardiomyopathy	0.0101	0.0118	CcSEcCtD
Guanabenz—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.00932	0.0109	CcSEcCtD
Guanabenz—ADRA2B—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00876	0.0601	CbGpPWpGaD
Guanabenz—Vasculitis—Furosemide—dilated cardiomyopathy	0.00874	0.0102	CcSEcCtD
Guanabenz—ADRA2C—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00819	0.0562	CbGpPWpGaD
Guanabenz—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00745	0.00872	CcSEcCtD
Guanabenz—Mental disability—Furosemide—dilated cardiomyopathy	0.0074	0.00867	CcSEcCtD
Guanabenz—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00723	0.00847	CcSEcCtD
Guanabenz—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00712	0.00833	CcSEcCtD
Guanabenz—ADRA2B—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0071	0.0487	CbGpPWpGaD
Guanabenz—Oliguria—Lisinopril—dilated cardiomyopathy	0.00695	0.00813	CcSEcCtD
Guanabenz—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00681	0.00797	CcSEcCtD
Guanabenz—ADRA2A—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00665	0.0456	CbGpPWpGaD
Guanabenz—ADRA2C—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00663	0.0455	CbGpPWpGaD
Guanabenz—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00659	0.00771	CcSEcCtD
Guanabenz—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00656	0.00768	CcSEcCtD
Guanabenz—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00656	0.00768	CcSEcCtD
Guanabenz—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00648	0.00759	CcSEcCtD
Guanabenz—Neck pain—Lisinopril—dilated cardiomyopathy	0.00648	0.00758	CcSEcCtD
Guanabenz—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00648	0.00758	CcSEcCtD
Guanabenz—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00636	0.00745	CcSEcCtD
Guanabenz—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00622	0.00728	CcSEcCtD
Guanabenz—Malaise—Spironolactone—dilated cardiomyopathy	0.00618	0.00724	CcSEcCtD
Guanabenz—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00614	0.00718	CcSEcCtD
Guanabenz—Discomfort—Spironolactone—dilated cardiomyopathy	0.00577	0.00675	CcSEcCtD
Guanabenz—Dehydration—Furosemide—dilated cardiomyopathy	0.00576	0.00674	CcSEcCtD
Guanabenz—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.0057	0.00667	CcSEcCtD
Guanabenz—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00566	0.00662	CcSEcCtD
Guanabenz—Confusional state—Spironolactone—dilated cardiomyopathy	0.00564	0.0066	CcSEcCtD
Guanabenz—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00564	0.0066	CcSEcCtD
Guanabenz—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00558	0.00653	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00558	0.00653	CcSEcCtD
Guanabenz—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00548	0.00641	CcSEcCtD
Guanabenz—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00539	0.00631	CcSEcCtD
Guanabenz—ADRA2A—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00539	0.037	CbGpPWpGaD
Guanabenz—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00534	0.00625	CcSEcCtD
Guanabenz—Eczema—Lisinopril—dilated cardiomyopathy	0.00517	0.00605	CcSEcCtD
Guanabenz—Injury—Lisinopril—dilated cardiomyopathy	0.00506	0.00592	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00483	0.00565	CcSEcCtD
Guanabenz—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00483	0.00565	CcSEcCtD
Guanabenz—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00476	0.00557	CcSEcCtD
Guanabenz—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00467	0.00546	CcSEcCtD
Guanabenz—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00461	0.0054	CcSEcCtD
Guanabenz—Face oedema—Lisinopril—dilated cardiomyopathy	0.00449	0.00525	CcSEcCtD
Guanabenz—Urticaria—Spironolactone—dilated cardiomyopathy	0.00444	0.0052	CcSEcCtD
Guanabenz—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00442	0.00518	CcSEcCtD
Guanabenz—Dehydration—Lisinopril—dilated cardiomyopathy	0.00432	0.00506	CcSEcCtD
Guanabenz—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00424	0.00497	CcSEcCtD
Guanabenz—Breast disorder—Lisinopril—dilated cardiomyopathy	0.0042	0.00492	CcSEcCtD
Guanabenz—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00418	0.0049	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00418	0.0049	CcSEcCtD
Guanabenz—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00412	0.00483	CcSEcCtD
Guanabenz—Gastritis—Lisinopril—dilated cardiomyopathy	0.00411	0.00481	CcSEcCtD
Guanabenz—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00405	0.00474	CcSEcCtD
Guanabenz—Influenza—Lisinopril—dilated cardiomyopathy	0.00402	0.0047	CcSEcCtD
Guanabenz—Eye disorder—Furosemide—dilated cardiomyopathy	0.004	0.00469	CcSEcCtD
Guanabenz—Tinnitus—Furosemide—dilated cardiomyopathy	0.00399	0.00468	CcSEcCtD
Guanabenz—Pruritus—Spironolactone—dilated cardiomyopathy	0.00396	0.00463	CcSEcCtD
Guanabenz—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00395	0.00462	CcSEcCtD
Guanabenz—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00387	0.00453	CcSEcCtD
Guanabenz—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00383	0.00448	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00373	0.00437	CcSEcCtD
Guanabenz—Malnutrition—Furosemide—dilated cardiomyopathy	0.00373	0.00437	CcSEcCtD
Guanabenz—Erythema—Furosemide—dilated cardiomyopathy	0.00373	0.00437	CcSEcCtD
Guanabenz—Dizziness—Spironolactone—dilated cardiomyopathy	0.0037	0.00433	CcSEcCtD
Guanabenz—Flatulence—Furosemide—dilated cardiomyopathy	0.00368	0.0043	CcSEcCtD
Guanabenz—Weight increased—Lisinopril—dilated cardiomyopathy	0.00365	0.00428	CcSEcCtD
Guanabenz—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00363	0.00425	CcSEcCtD
Guanabenz—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00362	0.00424	CcSEcCtD
Guanabenz—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00359	0.0042	CcSEcCtD
Guanabenz—Vomiting—Spironolactone—dilated cardiomyopathy	0.00356	0.00416	CcSEcCtD
Guanabenz—Rash—Spironolactone—dilated cardiomyopathy	0.00353	0.00413	CcSEcCtD
Guanabenz—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00352	0.00413	CcSEcCtD
Guanabenz—Vision blurred—Furosemide—dilated cardiomyopathy	0.00351	0.00411	CcSEcCtD
Guanabenz—Headache—Spironolactone—dilated cardiomyopathy	0.0035	0.0041	CcSEcCtD
Guanabenz—Anaemia—Furosemide—dilated cardiomyopathy	0.00345	0.00404	CcSEcCtD
Guanabenz—Agitation—Furosemide—dilated cardiomyopathy	0.00343	0.00401	CcSEcCtD
Guanabenz—Leukopenia—Furosemide—dilated cardiomyopathy	0.00334	0.00391	CcSEcCtD
Guanabenz—Nausea—Spironolactone—dilated cardiomyopathy	0.00332	0.00389	CcSEcCtD
Guanabenz—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00317	0.00371	CcSEcCtD
Guanabenz—Dry mouth—Furosemide—dilated cardiomyopathy	0.00311	0.00364	CcSEcCtD
Guanabenz—ADRA2B—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0031	0.0213	CbGpPWpGaD
Guanabenz—Confusional state—Furosemide—dilated cardiomyopathy	0.00307	0.00359	CcSEcCtD
Guanabenz—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00304	0.00356	CcSEcCtD
Guanabenz—Tinnitus—Lisinopril—dilated cardiomyopathy	0.003	0.00351	CcSEcCtD
Guanabenz—Shock—Furosemide—dilated cardiomyopathy	0.00299	0.00351	CcSEcCtD
Guanabenz—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00299	0.00349	CcSEcCtD
Guanabenz—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00298	0.00349	CcSEcCtD
Guanabenz—Skin disorder—Furosemide—dilated cardiomyopathy	0.00296	0.00346	CcSEcCtD
Guanabenz—Anorexia—Furosemide—dilated cardiomyopathy	0.0029	0.0034	CcSEcCtD
Guanabenz—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.0029	0.00339	CcSEcCtD
Guanabenz—ADRA2C—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00289	0.0199	CbGpPWpGaD
Guanabenz—Chills—Lisinopril—dilated cardiomyopathy	0.00288	0.00338	CcSEcCtD
Guanabenz—Hypotension—Furosemide—dilated cardiomyopathy	0.00284	0.00333	CcSEcCtD
Guanabenz—Malnutrition—Lisinopril—dilated cardiomyopathy	0.0028	0.00328	CcSEcCtD
Guanabenz—Erythema—Lisinopril—dilated cardiomyopathy	0.0028	0.00328	CcSEcCtD
Guanabenz—Flatulence—Lisinopril—dilated cardiomyopathy	0.00276	0.00323	CcSEcCtD
Guanabenz—Tension—Lisinopril—dilated cardiomyopathy	0.00275	0.00321	CcSEcCtD
Guanabenz—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00273	0.0032	CcSEcCtD
Guanabenz—Nervousness—Lisinopril—dilated cardiomyopathy	0.00272	0.00318	CcSEcCtD
Guanabenz—Back pain—Lisinopril—dilated cardiomyopathy	0.00271	0.00317	CcSEcCtD
Guanabenz—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00269	0.00315	CcSEcCtD
Guanabenz—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00265	0.0031	CcSEcCtD
Guanabenz—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00264	0.00309	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00263	0.00308	CcSEcCtD
Guanabenz—Fatigue—Furosemide—dilated cardiomyopathy	0.00262	0.00307	CcSEcCtD
Guanabenz—ADRA2B—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00261	0.0179	CbGpPWpGaD
Guanabenz—Constipation—Furosemide—dilated cardiomyopathy	0.0026	0.00305	CcSEcCtD
Guanabenz—Pain—Furosemide—dilated cardiomyopathy	0.0026	0.00305	CcSEcCtD
Guanabenz—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.0026	0.00304	CcSEcCtD
Guanabenz—Anaemia—Lisinopril—dilated cardiomyopathy	0.00259	0.00303	CcSEcCtD
Guanabenz—Angioedema—Lisinopril—dilated cardiomyopathy	0.00256	0.00299	CcSEcCtD
Guanabenz—Malaise—Lisinopril—dilated cardiomyopathy	0.00252	0.00295	CcSEcCtD
Guanabenz—ADRA2B—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00251	0.0172	CbGpPWpGaD
Guanabenz—Syncope—Lisinopril—dilated cardiomyopathy	0.00251	0.00294	CcSEcCtD
Guanabenz—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00251	0.00294	CcSEcCtD
Guanabenz—Leukopenia—Lisinopril—dilated cardiomyopathy	0.0025	0.00293	CcSEcCtD
Guanabenz—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00249	0.00291	CcSEcCtD
Guanabenz—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00246	0.00288	CcSEcCtD
Guanabenz—Cough—Lisinopril—dilated cardiomyopathy	0.00244	0.00286	CcSEcCtD
Guanabenz—ADRA2C—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00243	0.0167	CbGpPWpGaD
Guanabenz—Urticaria—Furosemide—dilated cardiomyopathy	0.00242	0.00283	CcSEcCtD
Guanabenz—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00241	0.00282	CcSEcCtD
Guanabenz—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00241	0.00282	CcSEcCtD
Guanabenz—Myalgia—Lisinopril—dilated cardiomyopathy	0.00238	0.00279	CcSEcCtD
Guanabenz—Chest pain—Lisinopril—dilated cardiomyopathy	0.00238	0.00279	CcSEcCtD
Guanabenz—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00238	0.00279	CcSEcCtD
Guanabenz—Anxiety—Lisinopril—dilated cardiomyopathy	0.00237	0.00278	CcSEcCtD
Guanabenz—Discomfort—Lisinopril—dilated cardiomyopathy	0.00235	0.00276	CcSEcCtD
Guanabenz—ADRA2A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00235	0.0161	CbGpPWpGaD
Guanabenz—ADRA2C—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00235	0.0161	CbGpPWpGaD
Guanabenz—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00233	0.00273	CcSEcCtD
Guanabenz—Confusional state—Lisinopril—dilated cardiomyopathy	0.0023	0.0027	CcSEcCtD
Guanabenz—Oedema—Lisinopril—dilated cardiomyopathy	0.00228	0.00267	CcSEcCtD
Guanabenz—Infection—Lisinopril—dilated cardiomyopathy	0.00227	0.00266	CcSEcCtD
Guanabenz—Shock—Lisinopril—dilated cardiomyopathy	0.00225	0.00263	CcSEcCtD
Guanabenz—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00224	0.00263	CcSEcCtD
Guanabenz—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00224	0.00262	CcSEcCtD
Guanabenz—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00223	0.00261	CcSEcCtD
Guanabenz—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00222	0.0026	CcSEcCtD
Guanabenz—Asthenia—Furosemide—dilated cardiomyopathy	0.00218	0.00256	CcSEcCtD
Guanabenz—Anorexia—Lisinopril—dilated cardiomyopathy	0.00218	0.00255	CcSEcCtD
Guanabenz—Pruritus—Furosemide—dilated cardiomyopathy	0.00215	0.00252	CcSEcCtD
Guanabenz—Hypotension—Lisinopril—dilated cardiomyopathy	0.00213	0.0025	CcSEcCtD
Guanabenz—ADRA2B—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00211	0.0145	CbGpPWpGaD
Guanabenz—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00208	0.00244	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00208	0.00244	CcSEcCtD
Guanabenz—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00205	0.0024	CcSEcCtD
Guanabenz—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00204	0.00238	CcSEcCtD
Guanabenz—Dizziness—Furosemide—dilated cardiomyopathy	0.00201	0.00236	CcSEcCtD
Guanabenz—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00201	0.00235	CcSEcCtD
Guanabenz—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00199	0.00232	CcSEcCtD
Guanabenz—ADRA2A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00198	0.0136	CbGpPWpGaD
Guanabenz—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00197	0.00231	CcSEcCtD
Guanabenz—ADRA2C—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00197	0.0135	CbGpPWpGaD
Guanabenz—Fatigue—Lisinopril—dilated cardiomyopathy	0.00197	0.0023	CcSEcCtD
Guanabenz—Pain—Lisinopril—dilated cardiomyopathy	0.00195	0.00229	CcSEcCtD
Guanabenz—Constipation—Lisinopril—dilated cardiomyopathy	0.00195	0.00229	CcSEcCtD
Guanabenz—Vomiting—Furosemide—dilated cardiomyopathy	0.00194	0.00227	CcSEcCtD
Guanabenz—Rash—Furosemide—dilated cardiomyopathy	0.00192	0.00225	CcSEcCtD
Guanabenz—Dermatitis—Furosemide—dilated cardiomyopathy	0.00192	0.00224	CcSEcCtD
Guanabenz—Headache—Furosemide—dilated cardiomyopathy	0.00191	0.00223	CcSEcCtD
Guanabenz—ADRA2A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00191	0.0131	CbGpPWpGaD
Guanabenz—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00188	0.0022	CcSEcCtD
Guanabenz—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00187	0.00219	CcSEcCtD
Guanabenz—Urticaria—Lisinopril—dilated cardiomyopathy	0.00181	0.00212	CcSEcCtD
Guanabenz—Nausea—Furosemide—dilated cardiomyopathy	0.00181	0.00212	CcSEcCtD
Guanabenz—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00181	0.00211	CcSEcCtD
Guanabenz—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00181	0.00211	CcSEcCtD
Guanabenz—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00168	0.00197	CcSEcCtD
Guanabenz—Asthenia—Lisinopril—dilated cardiomyopathy	0.00164	0.00192	CcSEcCtD
Guanabenz—Pruritus—Lisinopril—dilated cardiomyopathy	0.00162	0.00189	CcSEcCtD
Guanabenz—ADRA2A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0016	0.011	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00158	0.0109	CbGpPWpGaD
Guanabenz—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00156	0.00183	CcSEcCtD
Guanabenz—Dizziness—Lisinopril—dilated cardiomyopathy	0.00151	0.00177	CcSEcCtD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00148	0.0101	CbGpPWpGaD
Guanabenz—Vomiting—Lisinopril—dilated cardiomyopathy	0.00145	0.0017	CcSEcCtD
Guanabenz—Rash—Lisinopril—dilated cardiomyopathy	0.00144	0.00169	CcSEcCtD
Guanabenz—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00144	0.00988	CbGpPWpGaD
Guanabenz—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00144	0.00168	CcSEcCtD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00143	0.00982	CbGpPWpGaD
Guanabenz—Headache—Lisinopril—dilated cardiomyopathy	0.00143	0.00167	CcSEcCtD
Guanabenz—Nausea—Lisinopril—dilated cardiomyopathy	0.00136	0.00159	CcSEcCtD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00134	0.00918	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00124	0.00852	CbGpPWpGaD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0012	0.00824	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00116	0.00796	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00109	0.00745	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00106	0.00724	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000986	0.00676	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000942	0.00646	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000801	0.00549	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TTN—dilated cardiomyopathy	0.000738	0.00506	CbGpPWpGaD
Guanabenz—ADRA2B—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000716	0.00491	CbGpPWpGaD
Guanabenz—ADRA2B—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000716	0.00491	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TTN—dilated cardiomyopathy	0.000689	0.00473	CbGpPWpGaD
Guanabenz—ADRA2C—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000669	0.00459	CbGpPWpGaD
Guanabenz—ADRA2C—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000669	0.00459	CbGpPWpGaD
Guanabenz—ADRA2B—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000665	0.00457	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000664	0.00456	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000664	0.00456	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—ACTN2—dilated cardiomyopathy	0.00064	0.00439	CbGpPWpGaD
Guanabenz—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000638	0.00438	CbGpPWpGaD
Guanabenz—ADRA2C—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000622	0.00427	CbGpPWpGaD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00062	0.00426	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000618	0.00424	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000598	0.0041	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—ACTN2—dilated cardiomyopathy	0.000597	0.0041	CbGpPWpGaD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000577	0.00396	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000569	0.00391	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000569	0.00391	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TTN—dilated cardiomyopathy	0.00056	0.00384	CbGpPWpGaD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000559	0.00383	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—VCL—dilated cardiomyopathy	0.000544	0.00373	CbGpPWpGaD
Guanabenz—ADRA2A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000543	0.00373	CbGpPWpGaD
Guanabenz—ADRA2A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000543	0.00373	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000532	0.00365	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000532	0.00365	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000529	0.00363	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000512	0.00352	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000511	0.00351	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—VCL—dilated cardiomyopathy	0.000508	0.00349	CbGpPWpGaD
Guanabenz—ADRA2A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000505	0.00346	CbGpPWpGaD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000504	0.00346	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000494	0.00339	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—ACTN2—dilated cardiomyopathy	0.000485	0.00333	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000485	0.00333	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000479	0.00328	CbGpPWpGaD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000477	0.00327	CbGpPWpGaD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000469	0.00322	CbGpPWpGaD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000454	0.00311	CbGpPWpGaD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000453	0.00311	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000452	0.0031	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000438	0.003	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000433	0.00297	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000433	0.00297	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000432	0.00296	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000432	0.00296	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000426	0.00292	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000422	0.0029	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000415	0.00285	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000415	0.00285	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—VCL—dilated cardiomyopathy	0.000413	0.00283	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000409	0.00281	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000405	0.00278	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000405	0.00278	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000403	0.00277	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000401	0.00275	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000398	0.00273	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000395	0.00271	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ANKRD1—dilated cardiomyopathy	0.000392	0.00269	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00039	0.00268	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000389	0.00267	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000388	0.00266	CbGpPWpGaD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000388	0.00266	CbGpPWpGaD
Guanabenz—ADRA2B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000387	0.00266	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000376	0.00258	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000371	0.00255	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—TAZ—dilated cardiomyopathy	0.000369	0.00253	CbGpPWpGaD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000368	0.00252	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000364	0.0025	CbGpPWpGaD
Guanabenz—ADRA2C—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000362	0.00248	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000343	0.00235	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—SDHA—dilated cardiomyopathy	0.000333	0.00229	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000333	0.00229	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000332	0.00228	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000329	0.00226	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000329	0.00226	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000323	0.00222	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000318	0.00219	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000316	0.00217	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000315	0.00216	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000311	0.00214	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000308	0.00211	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000306	0.0021	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.000299	0.00206	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000296	0.00203	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000295	0.00203	CbGpPWpGaD
Guanabenz—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000294	0.00202	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000288	0.00197	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000285	0.00195	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000285	0.00195	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000282	0.00194	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—ITGB1—dilated cardiomyopathy	0.000273	0.00187	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000271	0.00186	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000271	0.00186	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000271	0.00186	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000264	0.00181	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—ITGB1—dilated cardiomyopathy	0.000255	0.00175	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000253	0.00174	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000245	0.00168	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000245	0.00168	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00024	0.00165	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000235	0.00161	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000234	0.0016	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000233	0.0016	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000229	0.00157	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000229	0.00157	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000228	0.00156	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000222	0.00153	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000222	0.00153	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000221	0.00151	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000219	0.00151	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000219	0.0015	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	0.000218	0.00149	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000214	0.00147	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000213	0.00146	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000208	0.00143	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000208	0.00143	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000207	0.00142	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000207	0.00142	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000206	0.00141	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	0.000205	0.00141	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0002	0.00137	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000193	0.00133	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000188	0.00129	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000187	0.00128	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000186	0.00128	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000186	0.00128	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000179	0.00123	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000178	0.00122	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000177	0.00121	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000176	0.00121	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000176	0.00121	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000173	0.00119	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000171	0.00117	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000169	0.00116	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000169	0.00116	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000167	0.00115	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000167	0.00115	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000167	0.00114	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000165	0.00113	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000162	0.00111	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00016	0.0011	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000157	0.00108	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000152	0.00104	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000152	0.00104	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000149	0.00103	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000148	0.00102	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000146	0.000999	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000143	0.000981	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000139	0.000952	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000138	0.000949	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000136	0.000933	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000136	0.00093	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000133	0.00091	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000131	0.000902	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000131	0.000902	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00013	0.000891	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00013	0.000889	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000126	0.000864	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000124	0.00085	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000123	0.000845	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000123	0.000842	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000123	0.000842	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000122	0.000838	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00012	0.000826	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000118	0.000812	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000118	0.000807	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000114	0.000783	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000112	0.000772	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000112	0.00077	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00011	0.000758	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.00011	0.000758	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000105	0.000722	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000101	0.000693	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000101	0.00069	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.97e-05	0.000684	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.97e-05	0.000684	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.58e-05	0.000658	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.56e-05	0.000656	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.44e-05	0.000648	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.27e-05	0.000636	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	9.13e-05	0.000627	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.12e-05	0.000626	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	9.06e-05	0.000622	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.98e-05	0.000616	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.95e-05	0.000614	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.88e-05	0.000609	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	8.82e-05	0.000605	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.35e-05	0.000573	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.24e-05	0.000565	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8e-05	0.000549	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	7.94e-05	0.000545	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.8e-05	0.000535	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.69e-05	0.000528	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.67e-05	0.000526	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	7.44e-05	0.000511	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	7.36e-05	0.000505	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.27e-05	0.000499	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	7.16e-05	0.000492	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	7.11e-05	0.000488	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	6.95e-05	0.000477	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	6.64e-05	0.000456	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	6.45e-05	0.000443	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.34e-05	0.000435	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.25e-05	0.000429	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.73e-05	0.000393	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	5.65e-05	0.000387	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	5.39e-05	0.00037	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.35e-05	0.000367	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	4.93e-05	0.000339	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	4.61e-05	0.000316	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.35e-05	0.000298	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.06e-05	0.000279	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	3.95e-05	0.000271	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.74e-05	0.000257	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.56e-05	0.000244	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.38e-05	0.000232	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	3.16e-05	0.000217	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.57e-05	0.000176	CbGpPWpGaD
